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Objective: To elucidate which anatomical sites need to be
sampled to detect human papillomavirus (HPV) infection in
the lower male genital tract.
Method: In an HPV survey of Mexican soldiers (median age
24 years; range 16–50 years), a cell sample from 2 cm
deep into the distal urethra (group 1; n = 168 men), or
0.5 cm deep into the meatus urethralis (group 2; n = 414
men) was collected, along with a sample from the external
genitalia. The different samples were tested for 27 HPV types
using a polymerase chain reaction based strip assay.
Results: HPV DNA was detected more frequently in external
genitalia samples (46.4%) than in the urethra (20.8%) or
meatus samples (12.1%). Lack of samples from the urethra or
meatus would have led to 5.1% and 1.5% false HPV negative
results, respectively. The most frequently detected high risk
HPV types (HPV 59, 52, 51, and 16) were similar in different
sites, whereas low risk types were found rarely in urethra
samples.
Conclusions: The addition of cell samples from the meatus to
those from external genitalia contributed negligibly to the
evaluation of the prevalence of HPV in men. HPV detection
was slightly improved by the addition of urethra samples, but
the gain may not justify the discomfort of the procedure in
large epidemiological studies.
T
he prevalence of human papillomavirus (HPV) in the
genital tract of men tends to be similar to that in women
(that is, between 3% and 40%, depending upon the
population and age group considered).1–8 It is unclear,
however, which genital sites need to be sampled to detect
HPV in men. Exfoliated cells were collected from the meatus
urethralis and from the distal urethra in certain studies,7 but
urethral sampling is painful and can potentially decrease
participation, especially in follow up studies.
We therefore compared the relative contribution of cell
samples from the external genitalia and the distal urethra or
meatus urethralis to the evaluation of HPV prevalence.
METHODS
The present report deals with the first 820 men recruited
between February 2001 and October 2002 in a larger study on
HPV prevalence in 1612 Mexican soldiers. An age stratified
random sample was drawn from a list of soldiers who were
attending a 1 year minimum period of service in central
Mexico. Overall, 7.5% of the men contacted refused to
participate in the study and 1.4% could not attend because of
concurrent illnesses. All study participants were fully
informed of study aims and procedures and signed an
informed consent form. The study was cleared by the ethics
committee of the National Institute of Public Health of
Mexico, and the International Agency for Research on
Cancer.
Participants were instructed not to wash their genitalia
12 hours before the urological examination. Samples were
collected using a cytobrush (Cytobrush Plus Sterile,
Medscand Medical Inc, Hollywood, FL, USA), moistened in
phosphate buffered saline (PBS), to brush the penis in a
continuously rotational movement, from bottom to top,
starting at the middle third of the scrotum. After retraction
of the prepuce (for uncircumcised men), the coronal sulcus,
the glans, and the tip of the penis were also brushed. The
cytobrush was then cut, and placed in a tube containing
20 ml of PBS.
Among two consecutive groups of men in the first part of
the study, a second cell sample was collected and placed in
PBS.
Group 1: among the first 298 men recruited in the study,
the second sample was taken from the distal urethra using a
pre-wetted Accellon Multi-Biosampler Swab (Medscand
Medical Inc, Hollywood, FL, USA), which was introduced
2 cm deep and rotated 360 degrees.
Group 2: among a subsequent group of 522 men, the second
sample was obtained from the meatus urethralis by opening
the tip of the penis and introducing a cotton swab 0.5 cm
deep into the urethra.
All samples were stored at 220 C̊ until shipment to the
Department of HPV Typing of the National Institute of Public
Health of Mexico, Cuernavaca, where the tubes were
vigorously vortexed, released cells centrifuged to remove
collection media, and the cell pellets re-suspended in two
aliquots of PBS solution and stored at 270 C̊.
HPV analysis
Testing for HPV in all samples was carried out by means of a
strip assay, using the reverse line blot format.9 HPV DNA was
amplified using biotinylated PGMY L1 consensus primers.10
To determine specimen adequacy, a fragment of the human b
globin gene was co-amplified with primers BGH20 and
BPC04. For HPV typing, the PCR products were hybridised to
probes immobilised on nylon strips. Each strip contained 29
probe lines, 27 type specific probes for HPV and two for high
and low concentrations of the b globin genes. HPV 16, 18, 31,
33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 were
considered high risk types and HPV 6, 11, 26, 40, 42, 53, 54,
55, 57, 66, 83, and 84 were considered low risk types.11
Hybridisation signals were detected by colorimetric develop-
ment. Strip interpretation was done using an acetate overlay
indicating the position of each type specific probe. The
hybridisation results were agreed upon independently by two
reviewers. For each PCR run, positive controls (Siha cells,
VPH 16 ATCC HTB-35, C 4 II cells VPH 18 ATCC CRL 1595)
Abbreviations: HPV, human papillomavirus; PBS, phosphate buffered
saline; PCR, polymerase chain reaction
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and a negative control (K 562 cells, (ATCC) CCL-243) were
included. These PCR products were also tested by reverse line
blot. After the exclusion of b globin negative samples (27.9%
of samples from external genitalia, 0% of those from the
urethra and 1.9% of those from the meatus), 168 men were
left in group 1 and 414 in group 2.
Statistical analysis
To simulate findings from a study where only external
genitalia samples were used, men who were HPV DNA
positive at external genitalia or urethra (group 1), or at
external genitalia or meatus (group 2), were considered true
HPV positives, whereas those who were positive at urethra or
meatus, but not at external genitalia, were considered false
HPV negatives.
RESULTS
The mean age of soldiers participating in the present study
was 22.9 (range = 16–41 years) in group 1 and 24.4 (range
17–50 years) in group 2. Only 13.4% reported not to have had
sexual intercourse and the mean number of lifetime sexual
partners among sexually active soldiers was 5.1 (range 1–39)
in group 1 and 4.1 (range 1–45) in group 2. Circumcision was
reported by 14.7% of men in group 1 and 6.9% of men in
group 2.
External genitalia samples were more frequently positive
for HPV (46.4%) compared to urethra (20.8%) or meatus
(12.1%) samples. Multiple type infections were found in
50.7% of the HPV positive samples from the external genitalia
and in 23.5% of HPV positive samples from the urethra/
meatus. High risk HPV types predominated in samples from
all sites (fig 1). HPV 59 was the most frequently detected high
risk type (8.4% of samples from the external genitalia and
2.7% of samples from the urethra/meatus). The next most
frequent high risk types in the external genitalia were HPV 52
(6.0%), HPV 51 (5.8%), HPV 16 (5.5%), and HPV 58 (4.6%),
whereas HPV 6, 11, 53 and, notably, HPV 84 were the low risk
types most frequently detected. The range of HPV types found
in urethra and meatus samples was similar to the range in
external genitalia samples, although all types showed
substantially lower prevalence (fig 1).
The largest contribution to the evaluation of HPV positivity
for all HPV types and for high risk and low risk types came
from external genitalia samples (table 1). Among the 79 HPV













































16 18 31 33 35 39 45 51 52 56 58 59 68 73 82 6 11 26 40 42 53 54 55 66 83 84
Figure 1 Prevalence of human
papillomavirus (HPV) DNA by type and
sample site among soldiers. Mexico,
2001–2. *HPV positivity, any type,
among 582 samples = 46.4%; HPV
positivity, any type, among 168
samples = 20.8%; `HPV positivity, any
type, among 414 samples = 12.1%.
High risk types = dark bars; Low risk
types = light bars.
Table 1 Detection of human papillomavirus (HPV) DNA
by sample site among 277 HPV positive soldiers. Mexico,
2001–2
HPV positivity No %
Group 1 (n = 79)
All types
Both sites 31 39.2
External genitalia only 44 55.7
Urethra only 4 5.1*
(1.4 to 12.5)
High risk
Both sites 26 42.6
External genitalia only 32 52.5
Urethra only 3 4.9*
(1.0 to 13.7)
Low risk
Both sites 7 17.1
External genitalia only 31 75.6
Urethra only 3 7.3*
(1.5 to 19.9)
Group 2 (n = 198)
All types
Both sites 47 23.7
External genitalia only 148 74.8
Meatus only 3 1.5*
(0.3 to 4.4)
High risk
Both sites 27 18.8
External genitalia only 114 79.2
Meatus only 3 2.1*
(0.4 to 6.0)
Low risk
Both sites 29 22.7
External genitalia only 98 76.6
Meatus only 1 0.8*
(0.0 to 4.3)
*Represents the proportion of false HPV negatives if only external
genitalia sample had been used; Corresponding 95% confidence
intervals.
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urethra sample only. Among the 198 HPV positive men in
group 2, three (1.5%) were HPV positive at the meatus
sample only.
When the agreement between external genitalia and
urethra or meatus samples (groups 1 and 2 combined) was
evaluated for selected HPV types, 0/25 infections with HPV 6,
2/27 with HPV 11, 2/34 with HPV 16, 3/27 with HPV 18, and
1/50 with HPV 59 were detected exclusively from the urethra
or meatus samples (data not shown).
DISCUSSION
HPV DNA in men was found substantially more frequently
on the skin of the external genitalia than in either the urethra
or meatus. It is difficult to speak about the sensitivity of
sampling different sites in men, as no recognised ‘‘gold
standard’’ exists. However, if we consider those in whom
HPV infection was detected in any of the examined sites
(external genitalia, or urethra, or meatus) as true HPV
positive men, sensitivity was quite high for the external
genitalia sample alone, while for the other sites it was very
low. The addition of the findings from the meatus would
have avoided 1.5% of false HPV negatives, and the addition of
urethra samples 5.1%. The passage of the sample from the
urethra through the meatus could have produced some
contamination, but this is unlikely to have substantially
affected HPV prevalence in the urethra as HPV positivity in
the meatus was shown to be rare.
In respect of individual HPV types, the frequent detection
of HPV 59 and HPV 84 in the external genitalia samples is
worth mentioning, as it had not been observed either in
Mexican women12 or HPV surveys in non-Mexican men.6–8
Major strengths of our study include the large size and the
virtually complete participation of the Mexican soldiers who
were invited. A limitation is represented by the difficulty of
obtaining sufficient cellular DNA from the external genitalia,
especially during the earliest study phase. The proportion of b
globin positive samples increased during the study, from 56%
in group 1 to 79% in group 2, possibly because of
improvements in the quality of cell collection and processing.
The difference was not the result of a difference in the
number of circumcised men as their proportion was similar
in groups 1 and 2 (15% and 7%, respectively) and their
exclusion did not eliminate the difference in b globin
positivity. A substantial increase in the proportion of b
globin positive samples from male genitalia has recently been
reported, by abrading the skin of external genitalia with
emery paper before swabbing with a moistened swab.4
In light of the large number of HPV types found in men, it
is reassuring that we did not find a substantial difference in
the distribution of HPV types in different anatomical sites.
Multiple type infections were twofold more frequent in HIV
positive samples from the external genitalia than in those
from the urethra or meatus, but high risk HPV types
predominated in all genital sites examined, and the most
common types were approximately the same.
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N Muñoz, Instituto Nacional de Cancerologı́a, Calle 1a No 9-85,
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3 Lazcano-Ponce E, Herrero R, Muñoz N, et al. High prevalence of human
papillomavirus infection in Mexican males: comparative study of penile-
urethral swabs and urine samples. Sex Transm Dis 2001;28:277–80.
4 Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and
sampling techniques for detection of human papillomavirus DNA in men.
J Infect Dis 2004;189:677–85.
5 Svare EI, Kjaer SK, Worm AM, et al. Risk factors for genital HPV DNA in men
resemble those found in women: a study of male attendees at a Danish STD
clinic. Sex Transm Infect 2002;78:215–18.
6 Shin HR, Franceschi S, Vaccarella S, et al. Prevalence and determinants of
genital infection with papillomavirus, in female and male university students in
Busan, South Korea. J Infect Dis 2004;190:468–76.
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Key messages
N HPV DNA prevalence in the external genitalia is very
high (46.4%) among young Mexican soldiers
N HPV DNA prevalence is substantially lower in the
urethra and meatus than in the external genitalia
N The most commonly detected HPV types were HPV 59,
84, 52, and 51
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